The role of synthetic progestogens in the medical management of menorrhagia

In: Clinical Disorders of the Endometrium and Menstrual Cycle · 1997 · pp. 167–174 · doi:10.1093/oso/9780192627247.003.0013 · W4388090782
book-chapter OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-13

Synthetic progestogens manage menorrhagia by inducing endometrial suppression, characterized by depleted glands and stromal decidualization.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Synthetic progestogens have been widely used in the treatment of heavy menstrual bleeding. The physiological background for this is the change of the endometrium which occurs after administration of progestogens indicative of endometrial suppression: small depleted glands lined with a thin epithelium and a more or less pronounced decidual transformation of the stroma.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK